These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 15797568)
1. Solubilization, stabilization, and purification of chemokine receptors using biosensor technology. Navratilova I; Sodroski J; Myszka DG Anal Biochem; 2005 Apr; 339(2):271-81. PubMed ID: 15797568 [TBL] [Abstract][Full Text] [Related]
2. A biosensor-based approach toward purification and crystallization of G protein-coupled receptors. Navratilova I; Pancera M; Wyatt RT; Myszka DG Anal Biochem; 2006 Jun; 353(2):278-83. PubMed ID: 16647033 [TBL] [Abstract][Full Text] [Related]
3. Analyzing ligand and small molecule binding activity of solubilized GPCRs using biosensor technology. Navratilova I; Dioszegi M; Myszka DG Anal Biochem; 2006 Aug; 355(1):132-9. PubMed ID: 16762304 [TBL] [Abstract][Full Text] [Related]
4. The role of cholesterol and sphingolipids in chemokine receptor function and HIV-1 envelope glycoprotein-mediated fusion. Ablan S; Rawat SS; Viard M; Wang JM; Puri A; Blumenthal R Virol J; 2006 Dec; 3():104. PubMed ID: 17187670 [TBL] [Abstract][Full Text] [Related]
5. A biosensor assay for studying ligand-membrane receptor interactions: binding of antibodies and HIV-1 Env to chemokine receptors. Hoffman TL; Canziani G; Jia L; Rucker J; Doms RW Proc Natl Acad Sci U S A; 2000 Oct; 97(21):11215-20. PubMed ID: 11005830 [TBL] [Abstract][Full Text] [Related]
6. High-level production, solubilization and purification of synthetic human GPCR chemokine receptors CCR5, CCR3, CXCR4 and CX3CR1. Ren H; Yu D; Ge B; Cook B; Xu Z; Zhang S PLoS One; 2009; 4(2):e4509. PubMed ID: 19223978 [TBL] [Abstract][Full Text] [Related]
7. HIV chemokine receptor inhibitors as novel anti-HIV drugs. Princen K; Schols D Cytokine Growth Factor Rev; 2005 Dec; 16(6):659-77. PubMed ID: 16005254 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of CCR5 on activated CD4 T cells in HIV-infected Indians. Dubey S; Khalid M; Wesley C; Khan SA; Wanchu A; Jameel S J Clin Virol; 2008 Sep; 43(1):25-31. PubMed ID: 18462992 [TBL] [Abstract][Full Text] [Related]
9. Capture and reconstitution of G protein-coupled receptors on a biosensor surface. Stenlund P; Babcock GJ; Sodroski J; Myszka DG Anal Biochem; 2003 May; 316(2):243-50. PubMed ID: 12711346 [TBL] [Abstract][Full Text] [Related]
10. Comparison of ligand-based and receptor-based virtual screening of HIV entry inhibitors for the CXCR4 and CCR5 receptors using 3D ligand shape matching and ligand-receptor docking. Pérez-Nueno VI; Ritchie DW; Rabal O; Pascual R; Borrell JI; Teixidó J J Chem Inf Model; 2008 Mar; 48(3):509-33. PubMed ID: 18298095 [TBL] [Abstract][Full Text] [Related]
11. HIV and the chemokine system: 10 years later. Lusso P EMBO J; 2006 Feb; 25(3):447-56. PubMed ID: 16437164 [TBL] [Abstract][Full Text] [Related]
12. Development of surface-based assays for transmembrane proteins: selective immobilization of functional CCR5, a G protein-coupled receptor. Silin VI; Karlik EA; Ridge KD; Vanderah DJ Anal Biochem; 2006 Feb; 349(2):247-53. PubMed ID: 16298323 [TBL] [Abstract][Full Text] [Related]
13. Surface plasmon resonance study of g protein/receptor coupling in a lipid bilayer-free system. Komolov KE; Senin II; Philippov PP; Koch KW Anal Chem; 2006 Feb; 78(4):1228-34. PubMed ID: 16478116 [TBL] [Abstract][Full Text] [Related]
14. BIACORE J: a new platform for routine biomolecular interaction analysis. Rich RL; Myszka DG J Mol Recognit; 2001; 14(4):223-8. PubMed ID: 11500968 [TBL] [Abstract][Full Text] [Related]
15. Electrostatic modeling of peptides derived from the V3-loop of HIV-1 gp120: implications of the interaction with chemokine receptor CCR5. Morikis D; Rizos AK; Spandidos DA; Krambovitis E Int J Mol Med; 2007 Mar; 19(3):343-51. PubMed ID: 17273779 [TBL] [Abstract][Full Text] [Related]
16. Breast milk CD4+ T cells express high levels of C chemokine receptor 5 and CXC chemokine receptor 4 and are preserved in HIV-infected mothers receiving highly active antiretroviral therapy. Kourtis AP; Ibegbu CC; Theiler R; Xu YX; Bansil P; Jamieson DJ; Lindsay M; Butera S; Duerr A J Infect Dis; 2007 Apr; 195(7):965-72. PubMed ID: 17330786 [TBL] [Abstract][Full Text] [Related]